Biohaven Therapeutics Ltd.

This study tested whether a new drug called BHV-7000 could safely reduce symptoms of major depression. It involved 336 adults with moderate to severe depression who were not taking other depression medications. Researchers compared the drug to a placebo over 6 weeks, measuring ch…

This study tested whether an investigational drug called BHV-7000 is safe and effective for quickly reducing symptoms of a manic episode in people hospitalized with Bipolar I Disorder. Over 270 adult participants received either the drug or a placebo (inactive substance) for 21 d…

This study tested a new medicine called BHV-2100 to see if it can safely and effectively stop migraine headaches. About 647 people with migraines received either the drug or a placebo pill when a migraine started. Researchers measured how many people were pain-free and free of th…